The Phosphatase Shp2 is Required for Signaling by the Kaposi's Sarcoma-associated Herpesvirus Viral GPCR in Primary Endothelial Cells

Overview

Journal Virology

Specialty Microbiology

Date 2009 Dec 17

PMID 20004456

Citations 9

Authors

Thomas Bakken

Meilan He

Mark L Cannon

Affiliations

Soon will be listed here.

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma (KS), an AIDS-related endothelial cell malignancy that is the most common cancer in central and southern Africa. The KSHV viral G protein-coupled receptor (vGPCR) is a viral oncogene that conveys a survival advantage to endothelial cells and causes KS-like tumors in mouse models. In this study we investigate the role of Shp2, a protein tyrosine phosphatase in vGPCR signaling. Shp2 is vital to many cytokine-induced signaling pathways and is dysregulated in various infections and malignancies. It has also recently been implicated in angiogenesis. We find that vGPCR activity results in phosphorylation of regulatory tyrosines in Shp2 and that in turn, Shp2 is required for vGPCR-mediated activation of MEK, NFkappaB, and AP-1. Furthermore, both genetic and chemical inhibition of Shp2 abrogate vGPCR-induced enhancement of endothelial cell migration. This establishes Shp2 as an important point of convergence of KSHV vGPCR signaling and a potential molecular target in the design of an anti-KSHV therapeutic regimen.

Citing Articles

Cancers associated with human gammaherpesviruses.

Wen K, Wang L, Menke J, Damania B FEBS J. 2021; 289(24):7631-7669.

PMID: 34536980 PMC: 9019786. DOI: 10.1111/febs.16206.

Protein Tyrosine Phosphatase SHP2 Suppresses Host Innate Immunity against Influenza A Virus by Regulating EGFR-Mediated Signaling.

Wang Q, Pan W, Wang S, Pan C, Ning H, Huang S J Virol. 2020; 95(6).

PMID: 33361428 PMC: 8094946. DOI: 10.1128/JVI.02001-20.

Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus.

Wong J, Damania B Biol Chem. 2017; 398(8):911-918.

PMID: 28284028 PMC: 5876722. DOI: 10.1515/hsz-2017-0101.

Mutations in the C-terminal region affect subcellular localization of crucian carp herpesvirus (CaHV) GPCR.

Wang J, Gui L, Chen Z, Zhang Q Virus Genes. 2016; 52(4):484-94.

PMID: 27059239 PMC: 4923094. DOI: 10.1007/s11262-016-1325-y.

Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.

Ganguli P, Chowdhury S, Chowdhury S, Sarkar R EURASIP J Bioinform Syst Biol. 2015; 2015(1):13.

PMID: 26660865 PMC: 4666900. DOI: 10.1186/s13637-015-0032-7.

References

Guo H, Browning P, Nicholas J, Hayward G, Tschachler E, Jiang Y . Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology. 1997; 228(2):371-8. DOI: 10.1006/viro.1996.8386. View

Qu C . The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res. 2001; 10(4):279-88. DOI: 10.1038/sj.cr.7290055. View

Yi T, Cleveland J, Ihle J . Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood. 1991; 78(9):2222-8. View

Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage F . In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272(5259):263-7. DOI: 10.1126/science.272.5259.263. View

Noren-Muller A, Reis-Correa Jr I, Prinz H, Rosenbaum C, Saxena K, Schwalbe H . Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc Natl Acad Sci U S A. 2006; 103(28):10606-11. PMC: 1502279. DOI: 10.1073/pnas.0601490103. View

Liu C, Sandford G, Fei G, Nicholas J . Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor. J Virol. 2004; 78(5):2460-71. PMC: 369212. DOI: 10.1128/jvi.78.5.2460-2471.2004. View

Liang Y, Ganem D . RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J Virol. 2004; 78(13):6818-26. PMC: 421686. DOI: 10.1128/JVI.78.13.6818-6826.2004. View

Nandan D, Yi T, Lopez M, Lai C, Reiner N . Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem. 2002; 277(51):50190-7. DOI: 10.1074/jbc.M209210200. View

Hellmuth K, Grosskopf S, Lum C, Wurtele M, Roder N, von Kries J . Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc Natl Acad Sci U S A. 2008; 105(20):7275-80. PMC: 2438240. DOI: 10.1073/pnas.0710468105. View

10.

Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka E, Gutkind J . G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 1998; 391(6662):86-9. DOI: 10.1038/34193. View

11.

Minoo P, Zadeh M, Rottapel R, Lebrun J, Ali S . A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood. 2003; 103(4):1398-407. DOI: 10.1182/blood-2003-07-2617. View

12.

Koch C, Anderson D, Moran M, Ellis C, Pawson T . SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science. 1991; 252(5006):668-74. DOI: 10.1126/science.1708916. View

13.

DAmbrosio D, Hippen K, Minskoff S, Mellman I, Pani G, Siminovitch K . Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science. 1995; 268(5208):293-7. DOI: 10.1126/science.7716523. View

14.

Mannell H, Hellwig N, Gloe T, Plank C, Sohn H, Groesser L . Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J Vasc Res. 2007; 45(2):153-63. DOI: 10.1159/000110081. View

15.

Neel B, Tonks N . Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997; 9(2):193-204. DOI: 10.1016/s0955-0674(97)80063-4. View

16.

Oka T, Yoshino T, Hayashi K, Ohara N, Nakanishi T, Yamaai Y . Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray. Am J Pathol. 2001; 159(4):1495-505. PMC: 1850490. DOI: 10.1016/S0002-9440(10)62535-7. View

17.

Lorenz U, Ravichandran K, Pei D, WALSH C, Burakoff S, Neel B . Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol Cell Biol. 1994; 14(3):1824-34. PMC: 358540. DOI: 10.1128/mcb.14.3.1824-1834.1994. View

18.

Nador R, Cesarman E, Chadburn A, Dawson D, Ansari M, Sald J . Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996; 88(2):645-56. View

19.

Whitby D, Howard M, Tenant-Flowers M, Brink N, Copas A, Boshoff C . Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995; 346(8978):799-802. DOI: 10.1016/s0140-6736(95)91619-9. View

20.

Guo H, Sadowska M, Reid W, Tschachler E, Hayward G, Reitz M . Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol. 2003; 77(4):2631-9. PMC: 141078. DOI: 10.1128/jvi.77.4.2631-2639.2003. View